Ikena Oncology Stock (NASDAQ: IKNA) stock price, news, charts, stock research, profile.
Open | - |
Close | - |
Volume / Avg. | 56.000 / 428.312K |
Day Range | - - - |
52 Wk Range | 1.020 - 7.640 |
Market Cap | $65.148M |
P/E Ratio | - |
Dividend Yield | - |
Exchange | NASDAQ |
RSI | 49 |
Short Interest | 3.35% |
Days to Cover | 3.31 |
Name |
---|
Revenue Change |
Gross Change |
EBITDA Change |
EBIT Change |
Earnings Change |
You can purchase shares of Ikena Oncology (NASDAQ: IKNA) through any online brokerage.
Other companies in Ikena Oncology’s space includes: SCYNEXIS (NASDAQ:SCYX), CalciMedica (NASDAQ:CALC), Jaguar Health (NASDAQ:JAGX), Ocuphire Pharma (NASDAQ:OCUP) and Marinus Pharma (NASDAQ:MRNS).
The latest price target for Ikena Oncology (NASDAQ: IKNA) was reported by HC Wainwright & Co. on Tuesday, March 19, 2024. The analyst firm set a price target for 11.00 expecting IKNA to rise to within 12 months (a possible 714.81% upside). 11 analyst firms have reported ratings in the last year.
The stock price for Ikena Oncology (NASDAQ: IKNA) is $1.35 last updated April 23, 2024 at 4:02 PM EDT.
There are no upcoming dividends for Ikena Oncology.
Ikena Oncology’s Q1 earnings are confirmed for Monday, May 13, 2024.
There is no upcoming split for Ikena Oncology.
Ikena Oncology is in the Health Care sector and Pharmaceuticals industry. They are listed on the NASDAQ.